Collection: GeNext Genomics

GeNext Genomics is working for development of recombinant proteins and monoclonal antibodies against clinically relevant targets through the integration of bioinformatics, recombinant DNA technology, proteomics and immunology using novel high-throughput technologies. 

GNG specializes in large scale expression and purification of native as well as recombinant proteins from virtually any source!  Major thrust area are diagnostic and therapeutic protein development, generation of antibody library using different platforms.